Status:
UNKNOWN
Imipenem in Critically Ill Patients
Lead Sponsor:
Prince of Songkla University
Conditions:
Critically Ill Patients With ECMO
Eligibility:
All Genders
18-90 years
Phase:
PHASE4
Brief Summary
Extracorporeal membrane oxygenation (ECMO) has become increasingly used for lifesaving respiratory and/or cardiac failure support in critically ill patients, including those with life-threatening seve...
Eligibility Criteria
Inclusion
- Patient age \>18 year
- Patients who diagnosed as severe sepsis
- Admitted into the ICU
- Supported with ECMO
Exclusion
- Patients who pregnant
- Patients who have documented hypersensitivity to carbapenem
Key Trial Info
Start Date :
December 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT03776305
Start Date
December 1 2015
End Date
December 30 2020
Last Update
February 15 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Division of Clinical Pharmacology, Department of Medicine, Faculty of Medicine, Prince of Songkla University
Hat Yai, Changwat Songkhla, Thailand, 90110